Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BORIS BAGDASARIAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1598758062
CMS profile
254429
Location
GLENDALE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$4,903.09

186 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,867.41 182
Consulting Fee $1,000.00 1
Education $35.68 3

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Puma Biotechnology, Inc. $1,118.95 6
E.R. Squibb & Sons, L.L.C. $303.87 17
Merck Sharp & Dohme Corporation $280.48 14
Amgen Inc. $243.77 9
AstraZeneca Pharmaceuticals LP $234.78 12
GENZYME CORPORATION $229.34 11
Genentech USA, Inc. $201.98 12
Karyopharm Therapeutics Inc. $164.83 5
PFIZER INC. $158.21 10
Seagen Inc. $137.99 6
Incyte Corporation $108.60 5
Teva Pharmaceuticals USA, Inc. $107.21 5
Exelixis Inc. $105.74 4
Novartis Pharmaceuticals Corporation $91.21 4
Alexion Pharmaceuticals, Inc. $90.51 4
Bayer HealthCare Pharmaceuticals Inc. $83.73 4
Eisai Inc. $79.16 4
Lexicon Pharmaceuticals, Inc. $69.69 3
Astellas Pharma US Inc $66.33 3
Regeneron Healthcare Solutions, Inc. $62.54 3
GlaxoSmithKline, LLC. $61.78 2
Celgene Corporation $60.47 3
Pharmacyclics LLC, An AbbVie Company $52.08 3
Janssen Biotech, Inc. $51.47 2
Taiho Oncology, Inc. $48.63 2
Boehringer Ingelheim Pharmaceuticals, Inc. $48.41 3
Dova Pharmaceuticals $45.19 2
Clovis Oncology, Inc. $43.50 2
TOLMAR Pharmaceuticals, Inc. $43.35 2
Rigel Pharmaceuticals, Inc. $34.51 2
Secura Bio, Inc. $33.66 2
EMD Serono, Inc. $28.80 1
Takeda Pharmaceuticals U.S.A., Inc. $27.15 1
Coherus Biosciences Inc. $26.63 1
Kyowa Kirin, Inc. $25.81 1
Integra LifeSciences Corporation $25.24 1
AbbVie Inc. $24.59 1
AMAG Pharmaceuticals, Inc. $24.43 1
Blueprint Medicines Corporation $24.40 1
Lilly USA, LLC $24.20 1
Acceleron Pharma, Inc. $23.52 1
TerSera Therapeutics LLC $21.15 1
Agios Pharmaceuticals, Inc. $21.09 1
Epizyme, Inc., $20.70 1
Foundation Medicine, Inc. $20.38 1
Kite Pharma, Inc. $19.92 1
ARRAY BIOPHARMA INC $19.58 1
Sirtex Medical Inc $19.32 1
BeiGene USA, Inc. $18.95 1
EUSA Pharma (US) LLC $13.91 1
Daiichi Sankyo Inc. $11.35 1

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BORIS BAGDASARIAN

NPI 1598758062 · CMS profile ID 254429

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

GLENDALE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598758062?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598758062?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598758062?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1598758062?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

186 matching records · $4,903.09 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 186 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 186.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $18.9309/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743353041 CMS
GlaxoSmithKline, LLC. $27.2009/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738761021 CMS
Exelixis Inc. $24.5809/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737176711 CMS
Seagen Inc. $20.7809/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732431991 CMS
Bayer HealthCare Pharmaceuticals Inc. $21.7909/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713635031 CMS
PFIZER INC. $18.8609/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743353097 CMS
AstraZeneca Pharmaceuticals LP $15.4309/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736395893 CMS
BeiGene USA, Inc. $18.9508/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752947387 CMS
Epizyme, Inc., $20.7008/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748602319 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.8608/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720667361 CMS
Karyopharm Therapeutics Inc. $34.4808/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751730977 CMS
TerSera Therapeutics LLC $21.1508/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747395573 CMS
Seagen Inc. $19.3908/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732431973 CMS
AstraZeneca Pharmaceuticals LP $19.6908/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736388817 CMS
PFIZER INC. $18.0908/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743306401 CMS
GENZYME CORPORATION $21.2208/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744180879 CMS
E.R. Squibb & Sons, L.L.C. $14.7308/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727929501 CMS
Celgene Corporation $21.5507/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727929565 CMS
E.R. Squibb & Sons, L.L.C. $21.5107/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727929369 CMS
Eisai Inc. $18.2507/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751215017 CMS
Regeneron Healthcare Solutions, Inc. $21.2507/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724412673 CMS
Puma Biotechnology, Inc. $29.1507/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750537693 CMS
Alexion Pharmaceuticals, Inc. $17.1207/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726628094 CMS
Teva Pharmaceuticals USA, Inc. $22.0107/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749486445 CMS
E.R. Squibb & Sons, L.L.C. $22.0207/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727929367 CMS
Amgen Inc. $25.5507/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740935485 CMS
Merck Sharp & Dohme Corporation $23.4007/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747732817 CMS
AstraZeneca Pharmaceuticals LP $13.3307/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736310153 CMS
TOLMAR Pharmaceuticals, Inc. $21.6807/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721462295 CMS
Exelixis Inc. $24.2707/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737176477 CMS
EMD Serono, Inc. $28.8007/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751282487 CMS
Lexicon Pharmaceuticals, Inc. $22.3607/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751837599 CMS
Merck Sharp & Dohme Corporation $24.0107/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747641965 CMS
Seagen Inc. $21.8107/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732431953 CMS
AstraZeneca Pharmaceuticals LP $18.9907/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735811597 CMS
Rigel Pharmaceuticals, Inc. $16.1206/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752093937 CMS
Genentech USA, Inc. $23.9206/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742989797 CMS
Karyopharm Therapeutics Inc. $33.6006/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751730993 CMS
Bayer HealthCare Pharmaceuticals Inc. $17.6506/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713618927 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.1506/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747333289 CMS
Dova Pharmaceuticals $22.7206/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752352901 CMS
GlaxoSmithKline, LLC. $34.5806/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738575555 CMS
Merck Sharp & Dohme Corporation $21.6006/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747664057 CMS
AstraZeneca Pharmaceuticals LP $15.7606/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735774599 CMS
Kyowa Kirin, Inc. $25.8106/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746863225 CMS
AstraZeneca Pharmaceuticals LP $23.9606/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735815553 CMS
Clovis Oncology, Inc. $24.9706/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722232661 CMS
Pharmacyclics LLC, An AbbVie Company $13.7906/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725667249 CMS
Taiho Oncology, Inc. $23.9506/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724401557 CMS
Incyte Corporation $23.3206/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745811529 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,153.88 253
PY2020 $4,903.09 186
PY2021 $3,824.69 176
PY2022 $4,722.98 189
PY2023 $5,465.64 209
PY2024 $6,506.08 248
PY2025 $7,192.17 240

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $8,140.00 3
PY2021 Principal investigator $21,557.00 2
PY2020 Principal investigator $2,150.70 3
PY2019 Principal investigator $2,498.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Secura Bio, Inc. $2,500.00 10/20/2022 Non-covered Recipient Entity
SCORA NETWORK LLC
CLBH589D2222 No dispute reported 06/30/2026 965257059
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,500.00 03/01/2022 Non-covered Recipient Entity
ADVENTIST HEALTH
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF LEE011 IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER WHO RECEIVED NO PRIOR HORMONAL THERAPY FOR ADVANCED DI No dispute reported 06/30/2026 910070379
Principal investigator 1 Novartis Pharmaceuticals Corporation $140.00 01/23/2022 Non-covered Recipient Entity
LOS ANGELES CANCER NETWORK
A PHASE II MULTICENTER THREE COHORT STUDY OF ORAL CMET INHIBITOR INC280 IN ADULT PATIENTS WITH EGFR WILD TYPE WT ADVANCED NON SMALL CELL LUNG CANCER NSCLC WHO HAVE RECEIVED ONE OR TWO PRIOR LINES OF SYSTEMIC THERAPY FORADVANCED METASTATIC DISEASE No dispute reported 06/30/2026 909403829